We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Personalized Medicine Likely Focus for New FDA Deputy Commissioner
Personalized Medicine Likely Focus for New FDA Deputy Commissioner
July 22, 2011
Expanding development of personalized products is a likely focus for the FDA’s new deputy commissioner for drugs and devices. However, ex-J&J exec Steven Spielberg, tapped for the position, told WDL it is too early to go into detail about this or his other goals.